These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12439438)

  • 1. Angiogenesis.
    Grossman JD; Grossman W
    Rev Cardiovasc Med; 2002; 3(3):138-44. PubMed ID: 12439438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative therapeutic strategies for patients with severe end-stage coronary artery disease not amenable to conventional revascularization.
    Almeda FQ; Parrillo JE; Klein LW
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):57-66. PubMed ID: 12929105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis for the treatment of inoperable coronary disease: the future.
    Sellke FW; Laham R; Suuronen EJ; Ruel M
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):184-8. PubMed ID: 16959748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy and angiogenesis in patients with coronary artery disease.
    Kastrup J
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1127-38. PubMed ID: 20670190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic therapy for coronary artery and peripheral arterial disease.
    Hughes GC; Annex BH
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):521-35. PubMed ID: 15889979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologically based myocardial regeneration: is there a role for the surgeon?
    Boodhwani M; Sodha NR; Sellke FW
    Curr Opin Cardiol; 2006 Nov; 21(6):589-94. PubMed ID: 17053409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions.
    Kinnaird T; Stabile E; Zbinden S; Burnett MS; Epstein SE
    Cardiovasc Res; 2008 May; 78(2):257-64. PubMed ID: 18178573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis of the heart.
    Kutryk MJ; Stewart DJ
    Microsc Res Tech; 2003 Feb; 60(2):138-58. PubMed ID: 12539168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis for myocardial ischemia.
    Rosinberg A; Khan TA; Sellke FW; Laham RJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):271-83. PubMed ID: 15151475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic angiogenesis for coronary artery disease. Contemporary results and perspectives].
    Dudek D; Heba G; Rzeszutko Ł; Dubiel JS
    Przegl Lek; 2001; 58(11):1000-3. PubMed ID: 11987827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical and percutaneous myocardial angiogenesis induction. Part I--laser revascularization.
    Gimelli G; Di Mario C; Dharmadhikari AV; Montorfano M; Anzuini A; Vaghetti M; Puchala-Borowik M; Airoldi F; Carlino M; Tzifos V; Maisano F; Alfieri O; Colombo A
    Ital Heart J; 2000 Dec; 1(12):785-94. PubMed ID: 11152409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA; Sellke FW; Laham RJ
    Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmyocardial laser revascularization: from randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions.
    Allen KB; Kelly J; Borkon AM; Stuart RS; Daon E; Pak AF; Zorn GL; Haines M
    Anesthesiol Clin; 2008 Sep; 26(3):501-19. PubMed ID: 18765220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular therapeutic modalities for arterial obstructive syndromes.
    Staudacher DL; Preis M; Lewis BS; Grossman PM; Flugelman MY
    Pharmacol Ther; 2006 Jan; 109(1-2):263-73. PubMed ID: 16243400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach.
    Horvath KA; Lu CY; Robert E; Pierce GF; Greene R; Sosnowski BA; Doukas J
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1071-7. PubMed ID: 15867782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis for the management of refractory angina: current concepts.
    Attanasio S; Schaer G
    Cardiovasc Ther; 2011 Dec; 29(6):e1-e11. PubMed ID: 20406245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease.
    Flynn A; O'Brien T
    IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for therapeutic angiogenesis and myogenesis in patients with advanced coronary disease.
    Ellis SG; Cura FA; Mukherjee D
    J Invasive Cardiol; 1999 Oct; 11(10):615-7. PubMed ID: 10745443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.